Vimarsana
Biggest News Aggregation in the World

Professor Eric Chan News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Professor Eric Chan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Professor Eric Chan Today - Breaking & Trending Today

'Energy stick' nasal inhalers are catching on among Singapore's youths: What are they and what risks do they pose to one's health? - Vimarsana News

'Energy stick' nasal inhalers are catching on among Singapore's youths: What are they and what risks do they pose to one's health?

SINGAPORE, March 11 — Priced under S$5 (RM17.60) and boasting flavours like “power mint” and “succulent grapes”, a new breed of nasal inhalers, known as energy sticks,...

PFAS in period underwear: Should you be worrying? - Vimarsana News

PFAS in period underwear: Should you be worrying?

How to make sure the menstrual products you're using are safe.

New urinary biomarkers could help monitor potential abuse of emerging synthetic cannabinoids - Vimarsana News

New urinary biomarkers could help monitor potential abuse of emerging synthetic cannabinoids

A team of scientists from the National University of Singapore (NUS) has successfully identified the urinary biomarkers of an emerging subclass of synthetic cannabinoids, called OXIZID, to monitor potential abuse.

New Drug Molecule poyendarone developed for Treatment of Atrial Fibrillation - Vimarsana News

New Drug Molecule poyendarone developed for Treatment of Atrial Fibrillation

AF is a serious condition that can lead to heart failure, early mortality and stroke. For AF patients, there are currently medications which are used to control AF and maintain normal rhythm.Some of...

Scientists develop an improved pharmaceutical drug for the treatment of atrial fibrillation - Vimarsana News

Scientists develop an improved pharmaceutical drug for the treatment of atrial fibrillation

Scientists from the National University of Singapore Department of Pharmacy have developed an improved pharmaceutical drug for the treatment of the most common heart rhythm disturbance – atrial fibrillation (AF).